tweetindex
FR

Novartis

@Novartis · Basel, Switzerland · joined 07 Nov 2008

An innovative medicines company working to reimagine medicine. See our community guidelines: https://t.co/wolzG1zLye

287 083Followers
512Following
13 252Posts total
17.7KViews on collected posts

Derniers posts

@Novartis Planning to run for POTUS in 2028. Soon to launch will be https://t.co/SoFhLP6ufT. Keep a lookout! 10 views · 0 likes · 0 reposts · 0 replies Open on X →
#Investors: Novartis delivered a solid second quarter, returning to sales growth driven by continued momentum from priority brands. We remain on track to deliver our full-year guidance and mid-term outlook.* Press release: https://t.co/AWqyHGRWD3 Webcast: https://t.co/knc 4.2K views · 12 likes · 1 reposts · 5 replies Open on X →
#NVSQ226 Novartis social media posts on Q2 2026 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ226 Novartis social media posts on Q2 4.2K views · 9 likes · 1 reposts · 1 replies Open on X →
On Tuesday, July 21, Novartis will announce its Q2 2026 results. Register to listen here: https://t.co/LIilPfqDRK #NovartisNews $NVS $NOVN #NVSQ226 https://t.co/sqBEM4SRYE 2.3K views · 11 likes · 0 reposts · 1 replies Open on X →
@Novartis I'm eagerly awaiting the launch of Rhapsido in Japan. As it’s a treatment for chronic urticaria that requires long-term use, I hope for an affordable price point. 43 views · 0 likes · 0 reposts · 1 replies Open on X →
@Novartis #illegal offer: force telemedicine and offers disabilitie Jobs to #People living in foregin countries. / big brother Tomaž Dereani is forcer 13 views · 1 likes · 0 reposts · 0 replies Open on X →
#Investors: Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We remain on track to deliver our full year guidance. Press release: https://t.co/c3x8o96Gsf IR Webcast: https://t.co/u5UJ 4.3K views · 22 likes · 2 reposts · 9 replies Open on X →
#NVSQ126 Novartis social media posts on Q1 2026 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ126 Novartis social media posts on Q1 2.6K views · 5 likes · 0 reposts · 3 replies Open on X →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.6K28 Apr
4.3K
1311 May
4311 Jul
2.3K20 Jul
4.2K21 Jul
4.2K
10

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.31%28 Apr
0.78%
7.69%11 May
2.33%11 Jul
0.53%20 Jul
0.26%21 Jul
0.42%
0.00%

Reactions — likes, reposts, replies and quotes — divided by views.

What the audience does

Likes66.7%60 in total
Reposts4.4%4 in total
Replies22.2%20 in total
Bookmarks6.7%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Comptes similaires